Medipharm Labs Corp T.LABS

1 million+ in volume today?

[subaru1i]

???

[checkup]

Unfortunate that the general market is having a pull back on the US debt rating news.   Great news for LABS and very glad to see.  

[subaru1i]

That's just how the market is for everyone day to day but on the positive side for LABS, we crossed the 21, 50, and 200 day moving price average as well as crossing the 10, 30, and 50 day volume moving averages.  

[Starkicker]

I noticed that, too. Very interesting, especially with current volumes. Should be an interesting month. I'm still holding pat tho.Not enough evidence to make me think this is going anywhere soon.

[subaru1i]

Starkicker, I'm curious....just so I understand you as an investor.   What evidence would you personally need to see that this company and stock is going somewhere?  Nothing wrong with being more conservative and playing it safe.  

[Olaf123]

vivo EBITDA + medif EBITDA = -5.7 or -3.7 with land sale

[subaru1i]

That's looking into the past which is a wonderful thing to do because the past provides us the opportunity to reflect and learn but companies, LABS included, look forward and plan for the future.  It's being able to see and share that vision of the company and to wait while the future arrives as the company has shown itself to making progress in the right direction.  As an

[subaru1i]

ps also:  Olaf, those are considered to 'one time events' (Vivo, land sale, Hexo settlement) and the real driver to EBITDA is 'reoccurring' volume sales.....we're are a lot closer now than ever before.  GL. 

[Olaf123]

or/and slashing costs. Yeah, I know. Just making sure.

[Starkicker]

Sure, no problem. My approach is 1) I never invest more than 5% of my portfolio in a speculative stock, and I'm aleady at that level with LABS 2) The sector remains incredibly unstable with overbearing legislation (Canada) or no legislation (US) 3) The current stock price leaves it open to being acquired. If it was valuable, it would already have been acquired 4) Potential for a reverse split

[subaru1i]

Thanks for sharing your thoughts Starkicker.   So I guess what this stock really needs then is a P.R. showing investors at least one big pharma customer and how much that is worth in terms of sales revenue to get things started to start building more investor confidence.   Even just one big pharma customer, one should want to see other big customers buying from LABS also so

[Starkicker]

You're welcome. Happy to share. I will admit there is a small part of me that wants to buy more, especially closer to end of Q3. If this thing does get some traction I'll be happy with a modest gain I'd make compared to larger gains that come with the higher risk of more investment. At any rate, I hope all investors of LABS ate rewarded for their patience.

[mdjbrown]

Right on s1i 964K shares traded so far this morning across all the platforms LABS - T  ATS 27.0 0.075 · 0.08 508.0 0.08 +0.01 14.3 964.9 65 190